所有图片(1)
About This Item
经验公式（希尔记法）:
C2H3Cl3O
CAS号:
分子量:
149.40
MDL编号:
UNSPSC代码:
12352104
EC索引号:
204-071-0
NACRES:
NA.22
方案:
≥97.0% (GC)
沸点:
151-153 °C/1013 hPa
蒸汽压:
1.3 hPa ( 20 °C)
推荐产品
蒸汽压
1.3 hPa ( 20 °C)
质量水平
方案
≥97.0% (GC)
表单
liquid
自燃温度
151 °C
效能
600 mg/kg LD50, oral (Rat)
pH值（酸碱度）
5-6 (20 °C in H2O, saturated solution)
沸点
151-153 °C/1013 hPa
mp
17-18 °C
转变温度
flash point >110 °C
密度
1.56 g/cm3 at 20 °C
储存温度
2-30°C
SMILES字符串
ClC(Cl)(Cl)CO
InChI
1S/C2H3Cl3O/c3-2(4,5)1-6/h6H,1H2
InChI key
KPWDGTGXUYRARH-UHFFFAOYSA-N
应用
- Assessment of EDDP Perchlorate Stability in Biological Samples: An investigation focused on the stability of methaDoneand its main metabolite, EDDP perchlorate, in oral fluids. The study highlighted the importance of understanding metabolite stability for accurate drug testing and monitoring in forensic and clinical settings (Fucci and De Giovanni, 2008).
- EDDP Perchlorate in Drug Testing: EDDP perchlorate was examined in a forensic context using the SPME technique to simultaneously detect multiple drugs of abuse in saliva. This method underscores the utility of EDDP perchlorate as a reliable biomarker in toxicology studies and drug monitoring (Fucci, De Giovanni, and Chiarotti, 2003).
- Pharmacological Action of MethaDoneand Metabolites: Research explored the interaction of methaDoneand its metabolites, including EDDP perchlorate, with rat alpha3beta4 nicotinic receptors. These findings contribute to the understanding of the pharmacodynamic properties of methadone′s metabolites, relevant in the development of therapeutic and diagnostic strategies (Xiao et al., 2001).
分析说明
含量测定（GC，面积%）： ≥ 97.0 %（a/a)
密度（d 20 °C/ 4 °C）：1.551 - 1.561
鉴别（IR）：符合检验
由于其特定的熔程，产物可以是固体、液体、固化熔体或过冷熔体。
密度（d 20 °C/ 4 °C）：1.551 - 1.561
鉴别（IR）：符合检验
由于其特定的熔程，产物可以是固体、液体、固化熔体或过冷熔体。
警示用语：
Danger
危险分类
Acute Tox. 4 Oral - Eye Dam. 1 - STOT SE 3
靶器官
Central nervous system
储存分类代码
10 - Combustible liquids
WGK
WGK 1
闪点(°F)
230.0 °F - closed cup
闪点(°C)
110 °C - closed cup
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门